Přeskočit na hlavní obsah

Příspěvky

Zobrazují se příspěvky z únor, 2011

Ceník přístrojů od kompletátorů - porovnejte

MEDICAL TRIBUNE CZ > Ceník přístrojů od kompletátorů - porovnejte


...Senátorka MUDr. Alena Dernerová píše pro měsíčník Občan v síti analýzu kontrolní činnosti při čerpání evropských peněz na nákup zdravotnických přístrojů. V článku najdete zajímavou tabulku porovnání běžných cen přístrojů s cenami, které "vysoutěžily" kompletátorské firmy nejen v Krajské zdravotní, ale i ve státem řízených nemocnicích...

Prostate Cancer Survival Unhurt by Intermittent Androgen Suppression - OncologySTAT

Prostate Cancer Survival Unhurt by Intermittent Androgen Suppression - OncologySTAT

...Continuous, lifelong androgen deprivation using an LHRH analogue has been the standard of care for men with PSA failure after radical prostate radiotherapy for the past 20 years. PR7 is a large, well-conducted phase III trial that compares this approach with intermittent therapy, using the LHRH analogue for 8 months at a time and then withholding further therapy until the PSA rises above 10 ng/mL. The trial provides good quality evidence that intermittent therapy is as effective as continuous treatment, and that in using the intermittent approach, patients will spend the majority of time off treatment. Given that intermittent therapy will be considerably cheaper than continuous treatment, and less morbid, it should be regarded as the new standard of care for men with PSA failure after radiotherapy......

Dexpanthenol

Dutina ústní


Rp.


Dexpanthenoli 5,0
Natrii benzoatis 0,15
Acidi citrici monohydr. 0,11
Aquae purificatae ad 100,0
M. f. sol.


užití


1–3× denně nanášet na postižená místaVýplachy úst a vlhké krytí: roztok se před použitím naředí stejným dílem čerstvě převařené vodyVýplachy úst: 3–4× denně asi 5–10 ml takto naředěného roztoku se 3 minuty ponechá v ústechPopáleniny , radiační dermatitis

Rp.
Dexpanthenoli 5,0 Glyceroli 85% 10,0 Alcoholis cetylstearylici 6,0 Glyceroli monostearatis 45–55 5,5 Polysorbati 80 2,0 Dimeticoni 2,0 Paraffini perliquidi 20,0 Aquae purificatae ad 100,0 M. f. crm D. S. 1–3× denně nanášet na postižená místa.
Oleokrém Rp.
Dexpanthenoli 5,0 Amygdalae olei raffin. 7,0 Aquae purificatae 30,0 Lanae alcohol. ung. 58,0 M. f. ung D. S. Nanášet 1–3x denně
Suchá kůže
Rp.
Dexpanthenoli  Ureae aa 5,0 Acidi lactici 1,0 Natrii lactatis sol. 50% 4,0 Glyceroli 85% 2,0 Dimeticoni 6,0 Aquae purificatae 14,0 Cutilan ad 100,0 M. f. crm D. S. Potírat několikrát denně.
zdroj

Praktické lékárenství,PharmDr. Jan Hašek,2010; 6(4)

Adultní tumor z buněk granulozy

Ve zkratce

nonepieteliálníhormonální sekrece - nejčastěji estrogeny, vzácněji androgenymax.výskyt kolem 60-ti let, jednostranněu 1/4 pacientek hyperplazie endometria až adenoca  (sekrece estrogenů)klinika - UZ cystické  pánevní rezistence v peri a postmenopauzálním věku50% produkce  protein S100-Bnádory do 5 cmstadia IAlze při příznivých histopatologických kriteriích ponechat pouze na dispenzarizaci - dispenzarizace doživotní - možnost  recidivy v dlouholetém odstupuprognostické faktory - kompletní operační výkon,nepřítomnost ruptury, velikost nádoru, jaderné atypie jinak chemoth - DDP, ADB , nebo BEPprognóza příznivá


Články



Nonepiteliální ZN ovarií – úskalí diagnostiky a managementuČíslo abstraktu: 024  Autoři: Kačírek J., Rob L., Robová H., Pluta M.Prognostic factors in ovarian adult granulosa cell tumourJ klin Pathol2008,61


Odkazy

Granulosa Cell TumorGranulosa Cell Tumor

New Target, Drug Potential Found for Colon Cancer

New Target, Drug Potential Found for Colon Cancer

In a study published online January 31st in the Journal of the National Cancer Institute, researchers from the Institute of Cancer Research (ICR) found that Sprycel, known generically as dasatinib and already used in other cancers, reduced bowel cancer cell growth in the lab by blocking the effects of an enzyme called lysyl oxidase, or LOX.

Calcium-Magnesium Combo Eases Oxaliplatin Sensory Effects

Calcium-Magnesium Combo Eases Oxaliplatin Sensory Effects

...The original plan had been to enroll 300 patients. But when only a third of that number had been randomized, unsubstantiated data from a separate trial testing FOLFOX (fluorouracil, leucovorin, and oxaliplatin) for colon cancer suggested that giving magnesium and calcium reduced the effectiveness of the treatment. Later, an independent review of that other trial eventually showed that in fact the magnesium/calcium group had a higher tumor response rate, but by then the current study had been closed.
The report by Dr. Loprinzi and colleagues includes data on 102 colon cancer patients on FOLFOX who received 1g calcium gluconate plus 1g magnesium sulfate pre- and post-oxaliplatin, or placebo. Data cutoff was done after four months and one week....

Molecular Markers May Improve Selection of Patients With Pancreatic Cancer for Surgery - OncologySTAT

Molecular Markers May Improve Selection of Patients With Pancreatic Cancer for Surgery - OncologySTAT


...in the cohort of 372 patients who underwent surgical resection for pancreatic cancer, the markers S100A2 and S100A4, which are associated with more aggressive tumor behavior, predicted worse survival after surgery. Median survival was almost three times longer when a tumor was immunohistochemically negative for both markers, compared with positive for S100A2 (34.3 vs. 11.9 months). A third group of patients having tumors positive only for S100A4 had intermediate survival (15.6 months)....

ERCC1 Expression Predicts Treatment Outcome in Esophageal Adenocarcinoma - OncologySTAT

ERCC1 Expression Predicts Treatment Outcome in Esophageal Adenocarcinoma - OncologySTAT

...Pretreatment expression of ERCC1 in localized esophageal and gastroesophageal adenocarcinomas is a marker for outcomes among patients given trimodality therapy that includes oxaliplatin-based chemoradiation, investigators reported from a prospective study.
Fully 58% of the 55 patients studied from the Southwest Oncology Group (SWOG) S0356 trial had tumors expressing a high level of mRNA for ERCC1, a key gene in the repair of platinum- and radiation-induced DNA damage.

FDA Warns of Possible Link Between Breast Implants and Rare Cancer - OncologySTAT

FDA Warns of Possible Link Between Breast Implants and Rare Cancer - OncologySTAT

The Food and Drug Administration is asking health care professionals to report any confirmed cases of anaplastic large cell lymphoma (ALCL) in women with silicone gel- or saline-filled breast implants, citing concerns about a possible association.